Hims & Hers, Novo Nordisk partner to offer weight-loss drug Wegovy
Americans with a prescription will have access to Novo Nordisk’s obesity drug Wegovy through the Hims & Hers platform for $599 monthly.
Americans with a prescription will have access to Novo Nordisk’s obesity drug Wegovy through the Hims & Hers platform for $599 monthly.
Assort Health, the most advanced specialty-specific AI platform for managing patient phone calls, today announced a new round of institutional financing co-l…
Glucotrack (Nasdaq:GCTK) announced today that it intends to participate in a bionic pancreas initiative in Europe.
Lifeward (Nasdaq:LFWD) announced today that it launched the next-generation ReWalk 7 personal exoskeleton in the United States.
Serve You Rx members will have maintenance meds delivered to their home and access to online services, including automatic refills and a pharmacist.
Patient advocacy startup Solace connects patients with healthcare advocates for personalized healthcare support, covered by Medicare in all 50 states.
Telix Pharmaceuticals’ prostate cancer PET imaging kit Illuccix has received marketing authorization in France and Finland.
New federal legislation could ease the payment path for medical AI by creating new Medicare reimbursement codes.
Based on learnings from a HIMSS CIO Connect session, Lateefah Agunbiade of Roanoke Chowan Community Health Center was able to collaborate with her organization’s CFO…
German medical device company seca released the first portable body composition scanner designed for primary care. The scanner seeks to give primary care providers a…
Cleveland-based MetroHealth System plans to roll out an enterprisewide AI platform to help improve clinical workflows. The public, safety-net health system will use healthcare AI…